immune system
• mutants exposed to S. aureus exhibit increased lymphoid infiltrate and bronchiolitis compared to wild-type
• mutants exposed to B. cepacia exhibit much more severe bronchopneumonia and mixed inflammatory infiltrate than wild-type
|
• mutants are unable to clear Staphylococcus aureus and Burkholderia cepacia from the lungs and develop lung disease after repeated bacterial exposure
|
respiratory system
N |
• under normal conditions (without bacterial exposure), no lung abnormalities are detected in homozygotes
|
• mutants exposed to S. aureus exhibit increased lymphoid infiltrate and bronchiolitis compared to wild-type
• mutants exposed to B. cepacia exhibit much more severe bronchopneumonia and mixed inflammatory infiltrate than wild-type
|
• mutants exhibit lung disease in response to repeated bacterial exposure
• mutants exhibit increased lymphoid infiltrate, goblet cell hyperplasia, mucus retention in the airways, bronchiolitis compared to wild-type after S. aureus infection
• mutants exhibit severe bronchopneumonia and mucus retention in the major airways, goblet cell hyperplasia and metaplasia, massive mixed inflammatory infiltrate, obliteration of smaller airways, and extensive oedema compared to wild-type after B. cepacia infection
|
• mutants exposed to bacteria (S. aureus and B. cepacia) exhibit increased goblet cell hyperplasia compared to wild-type
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
cystic fibrosis | DOID:1485 |
OMIM:219700 |
J:24119 |